Medical Instruments & Supplies · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Cooper Companies, Inc. publishes a filing, an earnings call transcript or a press release.
Get COO alertsBrian Andrews is recorded as CFO at Cooper Companies, Inc. (COO). The proxy statement of Cooper Companies, Inc. reports total compensation of $2,914,132 for Brian Andrews in fiscal 2022, including a base salary of $541,667. Disclosed compensation is on record for 5 fiscal years. Brian Andrews has spoken on 26 earnings calls across 1 company, most recently for Cooper Companies, Inc. on June 4, 2026. Cooper Companies, Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Cooper Companies, Inc. includes Albert G (CEO), Albert G. White III (CEO), Colleen E. Jay (Chairman) and 7 others.
“Most of my commentary will be on a non-GAAP basis, so please refer to today's earnings release for a reconciliation of GAAP to non-GAAP results. For the second fiscal quarter, consolidated revenue was $1.08 billion, representing an 8% increase year-over-year, or 5% on an organic basis.”
“Most of my commentary will be on a non-GAAP basis, so please refer to today's earnings release for a reconciliation of GAAP to non-GAAP results. First fiscal quarter consolidated revenue was $1.024 billion, up 6.2% year-over-year and up 2.9% organically.”
“Most of my commentary will be on a non-GAAP basis, so please refer to the earnings release for a reconciliation of GAAP to non-GAAP results. For the fourth fiscal quarter, consolidated revenues were $1.065 billion, up 4.6% and up 3.4% organically.”
“Most of my commentary will be on a non-GAAP basis. So please refer to the earnings release for a reconciliation of GAAP to non-GAAP results. For the third fiscal quarter, consolidated revenues were $1.06 billion up 5.7% as reported, and up 2% organically.”
“Most of my commentary will be on a non-GAAP basis, so please refer to the earnings release for a reconciliation of GAAP to non-GAAP results. For the second fiscal quarter, consolidated revenues were $1,002,000,000, up 6% as reported and up 7% organically.”
Medical Instruments & Supplies · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Cooper Companies, Inc. (COO) | CFO | $541,667 | $2,914,132 |
| 2021 | Cooper Companies, Inc. (COO) | CFO | $500,000 | $2,660,432 |
| 2020 | Cooper Companies, Inc. (COO) | CFO | $500,000 | $2,298,762 |
| 2019 | Cooper Companies, Inc. (COO) | CFO | $425,000 | $1,991,271 |
| 2018 | Cooper Companies, Inc. (COO) | CFO | $328,664 | $1,197,479 |